Carlsmed to Participate in Upcoming Investor Conferences

By GlobeNewswire

CARLSBAD, Calif., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that management will participate in the following investor conferences:

 Ninth Annual Evercore Healthcare Conference
 Format: Fireside chat
 Date: Monday, November 30, 2026
 Time: 12:55 p.m. Eastern time (9:55 a.m. Pacific time)
  
 Piper Sandler 38th Annual Healthcare Conference
 Format: Fireside chat
 Date: Wednesday, December 2, 2026 
 Time: 2:30 p.m. Eastern time (11:30 a.m. Pacific time)
  

Live and archived webcasts for these events will be available in the Events & Presentations section of the company’s investor website at investors.carlsmed.com.

About Carlsmed

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.

Investor Relations
IR@Carlsmed.com

Media
Marketing@Carlsmed.com
  


Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.